These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37196550)

  • 21. Salvage therapy with gemcitabine, vinorelbine, and pegylated liposomal doxorubicin for relapsed or refractory pediatric Hodgkin lymphoma. Results of a retrospective series of four children.
    Jaffray M; Buchbinder N; Lutun A; Schneider P; Piquenot JM; Vannier JP
    Ann Hematol; 2015 Aug; 94(8):1401-6. PubMed ID: 25862234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response rates, long term outcomes and toxicity profile of gemcitabine and vinorelbine based outpatient chemotherapy regimen in primary progressive and relapsed childhood Hodgkin lymphoma.
    Jan MRU; Saeed H; Abubakar M; Wali RM
    Leuk Lymphoma; 2020 Dec; 61(14):3369-3377. PubMed ID: 32924702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma.
    Michallet AS; Guillermin Y; Deau B; Lebras L; Harel S; Amorin S; Reynes C; Salles G; Subtil F; Brice P
    Haematologica; 2015 Jul; 100(7):e269-71. PubMed ID: 25840598
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer.
    Isokangas OP; Knuuttila A; Halme M; Mäntylä M; Lindström I; Nikkanen V; Viren M; Joensuu H; Mattson K
    Ann Oncol; 1999 Sep; 10(9):1059-63. PubMed ID: 10572603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New drugs in the treatment of Hodgkin's disease.
    Borchmann P; Schnell R; Diehl V; Engert A
    Ann Oncol; 1998; 9 Suppl 5():S103-8. PubMed ID: 9926247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rituximab combined with second line regimens for treatment of seven relapsed and refractory Hodgkin lymphoma patients].
    Liu H; Li H; Xiong W; Yi S; Zou D; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):578-82. PubMed ID: 26304082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma.
    Arai S; Letsinger R; Wong RM; Johnston LJ; Laport GG; Lowsky R; Miklos DB; Shizuru JA; Weng WK; Lavori PW; Blume KG; Negrin RS; Horning SJ
    Biol Blood Marrow Transplant; 2010 Aug; 16(8):1145-54. PubMed ID: 20197102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma.
    Chen JH; Chang PY; Yao NS
    Hematol Oncol Stem Cell Ther; 2009; 2(2):371-2. PubMed ID: 20118065
    [No Abstract]   [Full Text] [Related]  

  • 29. Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma.
    Pinczés LI; Szabó R; Illés Á; Földeák D; Piukovics K; Szomor Á; Gopcsa L; Miltényi Z
    Ann Hematol; 2020 Oct; 99(10):2385-2392. PubMed ID: 32748163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serious cutaneous toxicity following ifosfamide, gemcitabine and vinorelbine therapy in a patient with relapsed Hodgkin lymphoma and ichthyosis].
    Móciková H; Konífrová E; Stríteský J
    Cas Lek Cesk; 2009; 148(9):434-7. PubMed ID: 19899733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemometric Assisted UV-Spectrophotometric Methods Using Multivariate Curve Resolution Alternating Least Squares and Partial Least Squares Regression for Determination of Beta-Antagonists in Formulated Products: Evaluation of the Ecological Impact.
    Mostafa A; Shaaban H
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validated UHPLC-MS/MS assay for quantitative determination of etoposide, gemcitabine, vinorelbine and their metabolites in patients with lung cancer.
    Gong X; Yang L; Zhang F; Liang Y; Gao S; Liu K; Chen W
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28409868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma.
    Marr K; Ronsley R; Nadel H; Douglas K; Gershony S; Strahlendorf C; Davis JH; Deyell RJ
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28167. PubMed ID: 31925920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients.
    Uncu Ulu B; Dal MS; Yönal Hindilerden İ; Akay OM; Mehtap Ö; Büyükkurt N; Hindilerden F; Güneş AK; Yiğenoğlu TN; Başcı S; Kızıl Çakar M; Yanardağ Açık D; Korkmaz S; Ulaş T; Özet G; Ferhanoğlu B; Nalçacı M; Altuntaş F
    J Chemother; 2022 May; 34(3):190-198. PubMed ID: 34514960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
    Mian M; Farsad M; Pescosta N; Casini M; Cavattoni IM; Deola S; Cortelazzo S
    Ann Hematol; 2013 Jan; 92(1):121-3. PubMed ID: 22820997
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination chemotherapy with gemcitabine and vinorelbine in the treatment of patients with relapsed or refractory small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Erland JB; Baker M; Scullin DC; Shaffer DW; Greco FA;
    Cancer Invest; 2003 Apr; 21(2):193-9. PubMed ID: 12743984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid and sensitive determination of vinorelbine in human plasma by liquid chromatography-tandem mass spectrometry and its pharmacokinetic application.
    Qian J; Wang Y; Chang J; Zhang J; Wang J; Hu X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(9-10):662-8. PubMed ID: 21342795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine.
    Dubbelman AC; Tibben M; Rosing H; Gebretensae A; Nan L; Gorman SH; Robertson P; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():92-100. PubMed ID: 22426286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I study.
    Frasci G; Panza N; Comella P; Nicolella GP; Natale M; Pacilio C; Gravina A; Caputi V; Botti G; Comella G
    Ann Oncol; 1997 Oct; 8(10):1045-8. PubMed ID: 9402180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma.
    Pasricha SR; Grigg A; Catalano J; Leahy M; Underhill C; Arthur C; D'Rozario J; Lowenthal R; Reed K; Spencer A
    Cancer; 2008 Dec; 113(11):3192-8. PubMed ID: 18932253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.